2016
December
Multiple Sclerosis (MS) is an auto-immune illness in which the immune system attacks nerve cells in the brain by destroying some protective coating of the nerve cells. This results in problems of sending signals using these cells. A new drug has been developed that attacks the part of the immune system that is responsible for the damage to the nerve cells. Test results suggest that the new drug, Ocrelizumab, offers an effective treatment against MS. |